Abstract
Views on patent protection for drugs tend to align with opinions on the value of innovation. Brand-name pharmaceutical companies and international trade enthusiasts generally advocate for stronger intellectual property (IP) laws. Without the profits allowed by patent monopolies, they argue,
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
